Merck Selling Consumer Unit To Bayer For $14 Billion

As the pharmaceutical world waits to see if AstraZeneca will accept Pfizer’s $106 billion acquisition bid, two different major pharma players have struck a deal of their own: Merck has agreed to sell its consumer care segment to Germany’s Bayer AG for more than $14 billion.

Merck Selling Consumer Unit To Bayer For $14 Billion